Shalby [SHALBY] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison

Shalby

NSE
Loading...

Dr. Agarwal's Eye

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shalby wins in 7 metrics, Dr. Agarwal's Eye wins in 13 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShalbyDr. Agarwal's EyeBetter
P/E Ratio (TTM)1,122.6740.35Dr. Agarwal's Eye
Price-to-Book Ratio2.5911.14Shalby
Debt-to-Equity Ratio47.82158.94Shalby
PEG Ratio-23.301.81Shalby
EV/EBITDA27.2020.32Dr. Agarwal's Eye
Profit Margin (TTM)-0.05%13.96%Dr. Agarwal's Eye
Operating Margin (TTM)8.44%22.71%Dr. Agarwal's Eye
EBITDA Margin (TTM)8.44%22.71%Dr. Agarwal's Eye
Return on Equity0.63%26.07%Dr. Agarwal's Eye
Return on Assets (TTM)0.37%8.91%Dr. Agarwal's Eye
Free Cash Flow (TTM)$-757.89M$-83.80MDr. Agarwal's Eye
Dividend Yield0.65%0.11%Shalby
1-Year Return-1.79%4.92%Dr. Agarwal's Eye
Price-to-Sales Ratio (TTM)2.575.64Shalby
Enterprise Value$36.68B$26.43BShalby
EV/Revenue Ratio3.326.38Shalby
Gross Profit Margin (TTM)39.66%77.64%Dr. Agarwal's Eye
Revenue per Share (TTM)$88$881Dr. Agarwal's Eye
Earnings per Share (Diluted)$-0.08$123.07Dr. Agarwal's Eye
Beta (Stock Volatility)0.61-0.36Dr. Agarwal's Eye
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shalby vs Dr. Agarwal's Eye Stock Performance Analysis

Loading Price Chart...

Shalby
Dr. Agarwal's Eye
Shalby Stock Overview | Dr. Agarwal's Eye Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shalby0.80%7.74%35.22%42.91%25.35%15.19%
Dr. Agarwal's Eye-0.31%2.98%9.84%14.47%16.54%-23.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shalby-1.79%99.07%178.07%11.12%11.12%11.12%
Dr. Agarwal's Eye4.92%358.10%1,895.43%3,647.65%6,296.19%14,656.04%

News Based Sentiment: Shalby vs Dr. Agarwal's Eye

Shalby

News based Sentiment: MIXED

September presented a mixed bag for Shalby, with ambitious growth targets and a groundbreaking robotic surgery announcement offset by a decline in quarterly profits and cautious investor behavior. The insider buying provides a positive signal, but the overall picture is complex, requiring careful monitoring of execution and financial performance.

View Shalby News Sentiment Analysis

Dr. Agarwal's Eye

News based Sentiment: POSITIVE

September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.

View Dr. Agarwal's Eye News Sentiment Analysis

Performance & Financial Health Analysis: Shalby vs Dr. Agarwal's Eye

MetricSHALBYDRAGARWQ
Market Information
Market Cap i₹28.58B₹23.46B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,922,1791,476
90 Day Avg. Volume i1,363,7863,361
Last Close₹266.25₹4,950.65
52 Week Range₹177.25 - ₹278.15₹3,500.00 - ₹7,300.00
% from 52W High-4.28%-32.18%
All-Time High₹339.50 (Jan 22, 2024)₹7,300.00 (Dec 30, 2024)
% from All-Time High-21.58%-32.18%
Growth Metrics
Quarterly Revenue Growth0.06%0.17%
Quarterly Earnings Growth-0.46%0.22%
Financial Health
Profit Margin (TTM) i0.00%0.14%
Operating Margin (TTM) i0.08%0.23%
Return on Equity (TTM) i0.01%0.26%
Debt to Equity (MRQ) i47.82158.94
Cash & Liquidity
Book Value per Share (MRQ)₹101.79₹445.96
Cash per Share (MRQ)₹10.31₹52.76
Operating Cash Flow (TTM) i₹-417,020,000₹738.70M
Levered Free Cash Flow (TTM) i₹62.22M₹546.50M
Dividends
Last 12-Month Dividend Yield i0.65%0.11%
Last 12-Month Dividend i₹1.20₹5.00

Valuation & Enterprise Metrics Analysis: Shalby vs Dr. Agarwal's Eye

MetricSHALBYDRAGARWQ
Price Ratios
P/E Ratio (TTM) i1,122.6740.35
Forward P/E i28.05510.88
PEG Ratio i-23.301.81
Price to Sales (TTM) i2.575.64
Price to Book (MRQ) i2.5911.14
Market Capitalization
Market Capitalization i₹28.58B₹23.46B
Enterprise Value i₹36.68B₹26.43B
Enterprise Value Metrics
Enterprise to Revenue i3.326.38
Enterprise to EBITDA i27.2020.32
Risk & Other Metrics
Beta i0.61-0.36
Book Value per Share (MRQ) i₹101.79₹445.96

Financial Statements Comparison: Shalby vs Dr. Agarwal's Eye

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHALBYDRAGARWQ
Revenue/Sales i₹2.96B₹1.17B
Cost of Goods Sold i₹1.79B₹261.40M
Gross Profit i₹1.18B₹907.80M
Research & Development iN/AN/A
Operating Income (EBIT) i₹250.15M₹265.50M
EBITDA i₹485.47M₹379.30M
Pre-Tax Income i₹226.53M₹231.90M
Income Tax i₹149.75M₹59.30M
Net Income (Profit) i₹76.78M₹172.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHALBYDRAGARWQ
Cash & Equivalents i₹347.85M₹111.60M
Total Current Assets i₹6.58B₹559.40M
Total Current Liabilities i₹4.55B₹869.80M
Long-Term Debt i₹1.75B₹3.06B
Total Shareholders Equity i₹9.95B₹2.10B
Retained Earnings i₹4.44B₹1.99B
Property, Plant & Equipment i₹4.36B₹1.37B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHALBYDRAGARWQ
Operating Cash Flow i₹433.19MN/A
Capital Expenditures i₹-563.59MN/A
Free Cash Flow i₹-66.61MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHALBYDRAGARWQ
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,922,1791,476
Average Daily Volume (90 Day) i1,363,7863,361
Shares Outstanding i107.27M4.70M
Float Shares i30.91M1.11M
% Held by Insiders i0.77%0.81%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Shalby vs Dr. Agarwal's Eye

MetricSHALBYDRAGARWQ
Last 12-Month Dividend i₹1.20₹5.00
Last 12-Month Dividend Yield i0.65%0.11%
3-Year Avg Annual Dividend i₹1.08₹4.50
3-Year Avg Dividend Yield i0.55%0.12%
3-Year Total Dividends i₹3.23₹13.50
Ex-Dividend DateSep 19, 2024Nov 08, 2024